Oral Semaglutide Weight Loss Pill vs Injection: What the 2026 FDA Approval Means for You
For millions of Americans managing obesity, the arrival of a once-daily oral semaglutide weight loss pill has reframed the conversation around GLP-1 therapy in a meaningful way. After years of injectable options dominating the market, the 2026 FDA approval of a higher-dose oral semaglutide for chronic weight management offers a new path forward for people…